Article Text

other Versions

PDF
Hereditary spastic paraplegia caused by the PLP1 “rumpshaker mutation”
  1. Kirsten Svenstrup1,*,
  2. Geneviève Giraud2,
  3. Odile Boespflug-Tanguy2,
  4. Else R Danielsen3,
  5. Carsten Thomsen3,
  6. Kirsten Rasmussen4,
  7. Ian Law5,
  8. Asmus Vogel6,
  9. Jette Stokholm6,
  10. Clarissa Crone7,
  11. Lena E Hjermind1,
  12. Jørgen E Nielsen1
  1. 1 Section of Neurogenetics, Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark;
  2. 2 INSERM UMR 931-CNRS 6247, GReD, Clermont University, Faculty of Médecine Clermont-Ferrand, France;
  3. 3 Department of Radiology, Rigshospitalet, University Hospital of Copenhagen, Denmark;
  4. 4 Department of Clinical Genetics, University Hospital of Odense, Denmark;
  5. 5 Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University Hospital of, Denmark;
  6. 6 Memory Disorders Research Group, Rigshospitalet, University Hospital of Copenhagen, Denmark;
  7. 7 Department of Clinical Neurophysiology, Rigshospitalet, University Hospital of Copenhagen, Denmark
  1. Correspondence to: Kirsten Svenstrup, University of Copenhagen, Blegdamsvej 3b, build. 24.4, Copenhagen N, 2200, Denmark; ksvenstrup{at}sund.ku.dk

Abstract

Background: Hereditary spastic paraplegia (HSP) is a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive spasticity and weakness in the lower limbs. Mutations in PLP1 on the X chromosome cause spastic paraplegia type 2 (SPG2) or the allelic Pelizaeus Merzbacher Disease (PMD). The PLP1 protein is a major myelin protein involved in stabilisation and maintenance of the myelin sheath. The function of the protein has been studied in the rumpshaker mouse, which is a model of SPG2/PMD.

Objective: Characterization the human consequences of the “rumpshaker mutation”.

Patients: A second family with HSP caused by the “rumpshaker mutation”.

Results: The patients showed nystagmus during infancy and had early onset of HSP. They had normal cognition and MRI of the brains showed relatively unspecific white matter abnormalities on T2 sequences without clear progression. Urinary urgency was reported among the female carriers. MRS of both patients showed increased myo-inositol in the white matter, while decreased N-acetylaspartate was found exclusively in the oldest patient. All evoked potential examinations were compatible with severe central demyelination, while no signs of peripheral demyelination or axonal degeneration were found. 18F-FDG-PET scans were normal.

Conclusion: The phenotypes of the patients reported here are the mildest described to be caused by the rumpshaker mutation and represent the mildest form among the spectrum of PLP1 No definite symptoms in the female carriers could be ascribed to the mutation. Our data suggest the pathology to be an underlying dysmyelinating disorder in combination with a central axonal degeneration.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.